Status:
UNKNOWN
COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Sars-CoV2
Eligibility:
All Genders
18+ years
Brief Summary
Current management of VID-19 consists of oxygen support without specific treatment. Hospitalization may suddenly require delayed resuscitation. This evolution corresponds to an atypical acute respirat...
Eligibility Criteria
Inclusion
- Major Subject (≥18 years)
- Subject hospitalised in HUS or GHRMSA for COVID-19
- The diagnosis COVID-19 confirmed by smear or evoked by CT scan or chest X-ray without a differential diagnosis retained in the medical record
- Subjects who, after being informed, do not wish to have their data reused for the purposes of this research
Exclusion
- Subject who expressed opposition to participating in the study
- Subject under guardianship or trusteeship
- Subject under safeguard of justice
- Patient hospitalized in a geriatric service or in a ward not labeled COVID (surgery, oncology,...) or in a short-term hospitalization unit without transfer to another service.
- Serious patient on admission to the emergency room and recused from resuscitation.
Key Trial Info
Start Date :
April 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04412473
Start Date
April 30 2020
End Date
June 1 2021
Last Update
January 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Médecine Intensive et Réanimation
Strasbourg, France, 67091